ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2018 American Transplant Congress

    Chronic Narcotic Use Increases Mortality Rates in Heart Transplantation

    G. St. John, T. Chamogeorgakis, H. Nemeh, C. Tita, Y. Selektor, D. Lanfear, C. Williams.

    Transplant, Henry Ford Hospital, Detroit, MI.

    Purpose: In kidney and liver transplantation, chronic narcotic use pre and post-transplant has been associated with an increased risk for rejection and early graft loss.…
  • 2018 American Transplant Congress

    Efficacy of Bronchoscopically-Administered Surfactant in the Setting of Primary Graft Dysfunction after Lung Transplantation

    S. Ahmed,1 M. Soto-Arenall,1 D. Jackson,1 D. Erasmus.2

    1Department of Pharmacy, Mayo Clinic in Florida, Jacksonville, FL; 2Department of Transplantation, Mayo Clinic in Florida, Jacksonville, FL.

    Primary graft dysfunction (PGD) is a severe form of ischemia and reperfusion acute lung injury presenting within the first 72 hours post-lung transplant. PGD is…
  • 2018 American Transplant Congress

    Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation

    T. Hussaini,1,4 N. Partovi,1,4 E. Yoshida,2,4 S. Erb,2,4 C. Scudammore,3,4 S. Chung,3,4 V. Marquez.2,4

    1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; 2Faculty of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, BC, Canada; 3Faculty of Medicine, Division of Surgery, University of British Columbia, Vancouver, BC, Canada; 4Liver Transplant Program, Vancouver General Hospital, Vancouver, BC, Canada.

    Background:Acute kidney injury (AKI) in the setting of liver transplantation (LT) is a common and multifaceted complication. Recently, with the widespread adaptation of Acute Kidney…
  • 2017 American Transplant Congress

    Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.

    S. Hassan,1 F. Regan,2,3 C. Brown,4 A. Harmer,3 N. Anderson,3 P. Brookes,5 D. Taube,1 M. Willicombe.1

    1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom; 3NHS Blood and Transplant, London, United Kingdom; 4Histocompatibility and Immunogenetics, NHS Blood and Transplant, London, United Kingdom; 5Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom

    Introduction: Although it is well known that blood transfusions post-transplant are associated with the development of both HLA and donor specific antibodies [DSAs] and a…
  • 2017 American Transplant Congress

    Neutropenia in Kidney Transplantation: A Hidden Threat to Graft Survival.

    A. Vergottini, A. Karabala, P. Abrams, J. Verbesey, S. Ghasemian, J. Moore, M. Grafals, B. Javaid, M. Cooper, A. Gilbert.

    Medstar Georgetown Transplant Institute, Washington, DC

    IntroductionNeutropenia is a common complication after kidney transplantation resulting in a reduction of immunosuppression and the use of granulocyte colony-stimulating factors (G-CSF) which can increase…
  • 2017 American Transplant Congress

    α-Lipoc Acid Improve the Short Term Outcomes in Human Liver Transplantation.

    P. Casciato,1 N. Ambrosi,2 C. Fiorella,2 M. Vasquez,1 A. Gadano,1 M. de Santibañes,1 E. de Santibañes,1 M. Zandomeni,1 M. Chahdi,1 J. Laquinandi,1 P. Santofimia Castaño,3 J. Iovanna,3 E. Chuluyan,2 C. Incardona.4

    1Liver Transplantation Unit, Hospital Italiano, Buenos Aires, Argentina; 2CEFYBO, UBA-CONICET, Facultad de Medicina, Buenos Aires, Argentina; 3INSERM, Center of Research in Cancerology of Marseille (CRCM), Marseille, France; 4Fundación GADOR, GADOR, Buenos Aires, Argentina

    In liver transplantation (LT) the postreperfusion syndrome (PRS) is a serious intraoperative complication. The effect of α-lipoic acid (ALA) has not been evaluated. A double…
  • 2017 American Transplant Congress

    Waitlist Outcomes of Patients Re-Listed Following Failed Donation After Cardiac Death (DCD) Liver Transplant.

    K. Croome, D. Lee, A. Keaveny, C. Taner.

    Transplant, Mayo Clinic Florida, Jacksonville, FL

    Introduction: The outcome for patients re-listed after developing ischemic cholangiopathy(IC) or graft failure following liver transplant(LT) from a DCD donor, remains a significant concern. Better…
  • 2017 American Transplant Congress

    Prognostic Histopathologic Characteristics in Recurrent IgA Nephropathy: The Clinical Significance of Vascular Change.

    S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.

    Seoul National University Hospital, Seoul, Korea

    Background Although recurrent IgA nephropathy (IgAN) after kidney transplantation is known to cause lgraft failure, the clinical significance of histopathologic parameters in allografts needs further…
  • 2017 American Transplant Congress

    Impact of Peri-Transplant Viral Upper Respiratory Infection on Pediatric Liver Transplant Outcomes.

    J. Kohler,1 T. Miloh,1 K. Hosek,1 J. Goss,2 F. Munoz.1

    1Pediatrics, Baylor College of Medicine, Houston, TX; 2Surgery, Texas Children's Hospital, Houston, TX

    BACKGROUND: Viral upper respiratory infection (vURI) is common in children and its effect at the time of liver transplant (LT) on the post-operative outcomes is…
  • 2017 American Transplant Congress

    Impact of Alemtuzumab Induction on Hepatitis C Treatment Outcomes Post-Renal Transplantation.

    S. Jonchhe, J. Husson, J. Casale, R. Adekunle, P. Mathur, J. Gripshover, B. Ravichandran.

    University of Maryland Medical Center, Baltimore, MD

    BackgroundDirect-acting antiviral agents (DAAs) have improved treatment outcomes for Hepatitis C virus (HCV). Given high rates of treatment success with few side effects, eradication of…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences